| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.05 |